Winners to be Announced at AGILE Conference in May
DALLAS, March 11, 2025 /PRNewswire/ — Finalists have been announced for the 2025 Axxess Growth, Innovation and Leadership Experience (AGILE) conference’s Distinction Awards. This year more than 20 home health, hospice, palliative and home care organizations are finalists across four categories. The finalist organizations represent Axxess clients who have achieved excellence in areas of growth, innovation, quality and compliance.
“Congratulations to all of the finalists for this year’s AGILE Distinction Awards,” said Wendy Conlon, Senior Vice President of Client Experience at Axxess. “We are proud to recognize their outstanding achievements delivering care in the home. They are succeeding by letting their passions fuel their purpose-driven care and partnering with Axxess to bring that to life every day. I look forward to celebrating the finalists and the winners at our AGILE conference.”
There are four AGILE Distinction Award categories:
Winners of the AGILE Distinction Awards will be announced during the AGILE conference in Dallas, May 5-7. Registration for AGILE is open.
About Axxess
Axxess is the leading global technology platform for healthcare at home. The company offers a robust ecosystem that empowers healthcare organizations and professionals to deliver the highest quality care. By integrating with partners and payers from across the healthcare continuum, more than 9,000 organizations trust the Axxess network to care for more than 7 million patients worldwide. Multiple independent certifications have confirmed that Axxess has the most secure and industry-compliant software solutions. The company’s collaborative culture focused on innovation and excellence is recognized nationally as a “Best Place to Work.”
Contact: Johnathan Eaves
(903)445-6969
jeaves@axxess.com
SOURCE Axxess
NEW YORK CITY, NY / ACCESS Newswire / January 10, 2026 / The phrase best…
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…